Rank #1: Examining Consumer Cost Sharing and a Precision Benefit Design With Dr Mark Fendrick

Read the paper:
Cost Sharing and Branded Antidepressant Initiation Among Patients Treated With Generics: www.ajmc.com/journals/issue/2018/2018-vol24-n4/cost-sharing-and-branded-antidepressant-initiation-among-patients-treated-with-generics
Apr 18 2018
9mins
Rank #2: Improving Care While Reducing Costs Through ACOs and Other Value-Based Efforts

Feb 19 2019
21mins
Similar Podcasts
Inside Health Care: Presented by NCQA
Health Care News Podcast
Medicaid Leadership Exchange
The ACO Show
Relentless Health Value
Health Care Insider
Healthcare Intelligence Network
PopHealth Podcast
The Hospital Finance Podcast
Business of Healthcare
Navigant Healthcare Podcast Series
HFMA's Voices in Healthcare Finance
CMS: Beyond the policy
The #HCBiz Show!
The Change Healthcare Podcast
Rank #3: Using Medication Therapy Management to Optimize Medication Regimens, Identify Opioid Misuse

In an effort to provide greater incentive for Part D sponsors to use MTM programs, the Center for Medicare and Medicaid Innovation launched in January 2017 the 5-year Part D Enhanced Medication Therapy Management (eMTM) Model. The model is assessing whether incentives, such as payment and regulatory flexibilities, will result in enhancements in the MTM program, ultimately leading to improved patient outcomes and reduced costs.
In this podcast, we speak with Brian Litten, JD, chief strategic officer, Tabula Rasa HealthCare; and Calvin Knowlton, BScPharm, MDiv, PhD, chief executive officer and founder of Tabula Rasa HealthCare, to get more insight into MTM and the eMTM model.
Jul 10 2018
16mins
Rank #4: Bringing Virtual Tumor Boards, Real-Time Data to the Point of Care

Sep 04 2018
12mins
Most Popular Podcasts
Rank #5: This Week in Managed Care—Coverage From the JP Morgan Healthcare Conference and Other Health News

This week, the top managed care news included the FDA commissioner discussing boosting drug competition; BMS offering details on its acquisition of Celgene; and cancer mortality rates declining for the 25th consecutive year.
Read more about the stories in this podcast:
FDA's Scott Gottlieb, MD, Highlights Biosimilars Initiatives in J.P. Morgan Keynote Address: https://www.centerforbiosimilars.com/conferences/jp-morgan-2019/fdas-scott-gottlieb-md-highlights-biosimilars-initiatives-in-jp-morgan-keynote-address
BMS, Celgene Discuss $74 Billion Acquisition During JP Morgan Healthcare Conference: https://www.ajmc.com/newsroom/bms-celgene-discuss-74-billion-acquisition-during-jp-morgan-healthcare-conference
Cancer Mortality Rate Drops for the 25th Consecutive Year, but Socioeconomic Gap Widens: https://www.ajmc.com/focus-of-the-week/cancer-mortality-rate-drops-for-the-25th-consecutive-year-but-socioeconomic-gap-widens
Rise of Marijuana Cries Out for Research, Regulation, Physicians Say: https://www.ajmc.com/focus-of-the-week/rise-of-marijuana-cries-out-for-research-regulation-physicians-say
CVS Health CEO Outlines How Aetna Deal Will Benefit Customers: https://www.ajmc.com/newsroom/cvs-health-ceo-outlines-how-aetna-deal-will-benefit-customers
Jan 12 2019
5mins
Rank #6: What Is and Is Not in Trump’s Drug Pricing Plan: An Interview With Dr Michael Chernew

Mary Caffrey, the managing editor of The American Journal of Managed Care’s Evidence-Based series, spoke with Harvard healthcare economist Michael E. Chernew, PhD, who is the co-editor in chief of AJMC, to discuss elements of the Trump administration proposal to control drug prices. Chernew is also a former vice chair of the Medicare Payment Advisory Commission.
Read more:
Trump Offers Blueprint to Drive Down Prescription Drug Prices; Targets Rebates, "Middlemen": www.ajmc.com/newsroom/-trump-offers-blueprint-to-drive-down-prescription-drug-prices-targets-rebates-middlemen
Azar Stumps for Plan to Hold Down Prescription Drug Costs: www.ajmc.com/focus-of-the-week/azar-stumps-for-plan-to-hold-down-prescription-drug-costs
Trump Targets Drug Prices, Right-to-Try in State of the Union: www.ajmc.com/newsroom/trump-targets-drug-prices-righttotry-in-state-of-the-union
Will Trump Take Steps to Rein in Drug Prices?: www.ajmc.com/focus-of-the-week/will-trump-take-steps-to-rein-in-drug-prices
May 22 2018
16mins
Rank #7: Tackling the Opioid Epidemic With a Public Health Approach

Mar 06 2017
13mins
Rank #8: Lowering Costs And Readmission Rates Through a Meal Delivery Program

Jun 12 2018
9mins
Rank #9: This Week in Managed Care—New Hypertension Guidelines, and Other Health News

High Blood Pressure Starts at 130/80, New Guidelines Say: www.ajmc.com/conferences/aha-2017/80-new-guidelines-say
Trump Nominates Alex Azar, Former Lilly Executive, to Lead HHS: www.ajmc.com/newsroom/trump-nominates-alex-azar-former-lilly-executive-to-lead-hhs
Kaiser Analysis: For Many, Health Coverage Costs Less Than Individual Mandate Penalty: www.ajmc.com/focus-of-the-week/kaiser-analysis-for-many-health-coverage-costs-less-than-individual-mandate-penalty
Patient-Centered Oncology Care: www.ajmc.com/conferences/pcoc-2017/
Nov 19 2017
5mins
Rank #10: Addressing the Complexities of Value-Based Payment Models

Jul 23 2019
18mins
Rank #11: How a Self-Insured Employer Decreased Costs While Improving Performance

Apr 23 2019
9mins
Rank #12: This Week in Managed Care—New Direction for CMS Innovation Center, and Other Health News

This week, the top managed care stories included a new direction for the Center for Medicare and Medicaid Innovation; a bipartisan group of governors spoke out against the latest effort to repeal the Affordable Care Act; and the World Health Organization warned that antibiotics currently being developed were not enough to fight antibiotic-resistant infections.
Sep 22 2017
6mins
Rank #13: Addressing Financial Toxicity With Navigators and Better Conversations Around Decision Making

This episode of Managed Care Cast includes conversations with a few experts in the field: Yousuf Zafar, MD, MHS, of the Duke Cancer Institute; Clara Lambert, BBA, OPN-CG, chair of the Association of Community Cancer Centers Financial Advocacy Network Advisory Committee; Todd Yezefski, MD, senior fellow in the Clinical Research Division at the Fred Hutchinson Cancer Research Center and Division of Medical Oncology at the University of Washington; and Michele McCourt, senior director of the CancerCare Co-Payment Assistance Foundation.
Read more:
A Descriptive Study of Patients Receiving Foundational Financial Assistance Through Local Specialty Pharmacies: www.ajmc.com/journals/supplement/2018/the-patient-assistance-safety-net-how-many-need-help-how-many-are-helped/a-descriptive-study-of-patients-receiving-foundational-financial-assistance-through-local-specialty-pharmacies
Impact of Trained Oncology Financial Navigators on Patient Out-of-Pocket Spending: www.ajmc.com/journals/supplement/2018/the-patient-assistance-safety-net-how-many-need-help-how-many-are-helped/impact-of-trained-oncology-financial-navigators-on-patient-outofpocket-spending
Policy Improvement Areas to Reduce Financial Hardship: www.ajmc.com/conferences/pan-2018/policy-improvement-areas-to-reduce-financial-hardship
Addressing Financial Concerns at the Outset to Improve Patient Outcomes: www.ajmc.com/conferences/pan-2018/addressing-financial-concerns-at-the-outset-to-improve-patient-outcomes
Jun 05 2018
9mins
Rank #14: This Week in Managed Care—Tracking Drug Price Hikes and Other Health News

This week, the top managed care news included the Institute for Clinical and Economic Review investigating rising drug prices; CMS expanding value-based insurance design; and researchers using a blood test to detect preclinical Alzheimer disease.
Read more about the stories in this podcast:
What's Driving US Healthcare Costs? Stakeholders Weigh In: https://www.ajmc.com/focus-of-the-week/whats-driving-us-healthcare-costs-stakeholders-weigh-in
ICER Will Review If Drug Price Hikes Are Supported by New Evidence: https://www.ajmc.com/newsroom/icer-will-review-if-drug-price-hikes-are-supported-by-new-evidence
Report: Increasing Drug Prices, Shortages Causing Hospitals to Cut Staff, Putting Patient Safety at Risk: https://www.ajmc.com/focus-of-the-week/report-increasing-drug-prices-shortages-causing-hospitals-to-cut-staff-putting-patient-safety-at-risk
What We're Reading: Insulin Costs Double; PhRMA's Record Spending; Causes of Liver Transplants: https://www.ajmc.com/newsroom/what-were-reading-insulin-costs-double-phrmas-record-spending-causes-of-liver-transplants
CMS Expands VBID in Medicare Advantage, Increases Risk Sharing in Part D: https://www.ajmc.com/newsroom/cms-expands-vbid-in-medicare-advantage-increases-risk-sharing-in-part-d
Researchers Use Blood Test to Detect Preclinical Alzheimer Disease Signs: https://www.ajmc.com/newsroom/researchers-use-blood-test-to-detect-preclinical-alzheimer-disease-signs
Improving Care for Patients With Metastatic Breast Cancer: https://www.ajmc.com/peer-exchange/advances-metastatic-breast-cancer/improving-care-for-patients-with-metastatic-breast-cancer
Jan 26 2019
5mins
Rank #15: Takeaways From the ACO Coalition Fall 2016 Meeting

Here we present key takeaways from the sessions and panels presented at the Coalition meeting in Philadelphia in the words of the presenters themselves.
Dec 30 2016
8mins
Rank #16: The Many Uses of Big Data by Clinical Pharmacists

Oct 22 2019
33mins
Rank #17: Discussing the ACO Learning Curve and Ochsner's Success With Accountable Care

David Carmouche, MD, president of the Ochsner Health Network and executive director of the Ochsner Accountable Care Network, explains how the Ochsner accountable care organization (ACO) was able to find success and how other ACOs can get over the learning curve to achieve savings.
Learn more about Ochsner
https://www.ajmc.com/partners/ochsner
Oct 29 2019
16mins
Rank #18: Cancer Survivorship: The Challenges That Remain After Treatment

Aug 23 2017
16mins
Rank #19: Healthcare Needs More Chief Wellness Officers to Address Burnout and Its Impact

Greater attention to the issue, and the impact it can have on patient outcomes, has led to more organizations to implement interventions to address and alleviate burnout in healthcare. Bernadette Melnyk, PhD, RN, APRN-CNP, FAANP, FNAP, FAAN, vice president for health promotion, chief wellness officer and professor and dean of the college of nursing at The Ohio State University, highlighted the need for a chief wellness officer, same as healthcare has chief technology and quality officers, and some interventions being implemented.
Learn more about burnout:
Making The Case For The Chief Wellness Officer In America’s Health Systems: A Call To Action: https://www.healthaffairs.org/do/10.1377/hblog20181025.308059/full/
Physicians Are Pessimistic About Future of Healthcare, Highlight Extent of Social Determinants: https://www.ajmc.com/focus-of-the-week/physicians-are-pessimistic-about-future-of-healthcare-highlight-extent-of-social-determinants
Physician Burnout Associated With Poorer Patient Outcomes: https://www.ajmc.com/focus-of-the-week/physician-burnout-associated-with-poorer-patient-outcomes
Dr W. Clay Jackson Discusses Identifying, Addressing Clinician Burnout: https://www.ajmc.com/conferences/psychcongress2018/dr-w-clay-jackson-discusses-identifying-addressing-clinician-burnout
Will HHS' Strategy to Address Health IT–Related Physician Burden Provide Relief for Providers? https://www.ajmc.com/focus-of-the-week/will-hhs-strategy-to-address-health-itndashrelated-physician-burden-provide-relief-for-providers
After Increasing for Several Years, Physician Burnout Shows Modest Decline: https://www.ajmc.com/newsroom/after-increasing-for-several-years-physician-burnout-shows-modest-decline
Apr 16 2019
17mins
Rank #20: This Week in Managed Care—CBO Rates Healthcare Bill, and Other News

Mar 17 2017
4mins